U.S., March 17 -- ClinicalTrials.gov registry received information related to the study (NCT07474311) titled 'A Real-World Study of Clinical Use of Available Treatments for Pediatric Patients With Spinal Muscular Atrophy' on March 11.

Brief Summary: The aim of this study was to evaluate real-world treatment patterns and clinical outcomes in pediatric SMA patients in the Czech and Slovak Republics, using data from the Registry of muscular Dystrophy (REaDY).

Study Start Date: Nov. 22, 2011

Study Type: OBSERVATIONAL

Condition: Muscular Atrophy, Spinal

Recruitment Status: COMPLETED

Sponsor: Novartis Pharmaceuticals

Published by HT Digital Content Services with permission from Health Daily Digest....